Amprenavir

Scientific Name:	Amprenavir
Brand Name:	Not Available
Company Owner:	Glaxosmithkline
Mechanism Of Action	Amprenavir inhibits the HIV viral proteinase enzyme which prevents cleavage of the gag-pol polyprotein, resulting in noninfectious, immature viral particles.
Description of the Drug:	Amprenavir is a protease inhibitor used to treat HIV infection.
Protein Data Bank:	https://www.rcsb.org/structure/3SM2 https://www.rcsb.org/structure/6P9B https://www.rcsb.org/structure/3S45 https://www.rcsb.org/structure/5T8H https://www.rcsb.org/structure/4J5J https://www.rcsb.org/structure/3EKP https://www.rcsb.org/structure/3NUO https://www.rcsb.org/structure/5KR0 https://www.rcsb.org/structure/7N6V https://www.rcsb.org/structure/4JEC https://www.rcsb.org/structure/4RVJ https://www.rcsb.org/structure/6XCT https://www.rcsb.org/structure/1HPV https://www.rcsb.org/structure/3NUJ https://www.rcsb.org/structure/3NU9 https://www.rcsb.org/structure/3S43 https://www.rcsb.org/structure/3EKV https://www.rcsb.org/structure/3NU6 https://www.rcsb.org/structure/7N6X https://www.rcsb.org/structure/3NU5 https://www.rcsb.org/structure/3NU4 https://www.rcsb.org/structure/3OXV https://www.rcsb.org/structure/1T7J https://www.rcsb.org/structure/3NU3 https://www.rcsb.org/structure/3EM3

Source: DrugBank Online – DrugBank.com. Retrieved 2023-01-23 from https://go.drugbank.com/drugs/DB00701

Drugs A - Z